Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy
Authors
Keywords
-
Journal
Neurology-Neuroimmunology & Neuroinflammation
Volume 9, Issue 4, Pages e1184
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-05-24
DOI
10.1212/nxi.0000000000001184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotherapy‐based approach is the preferred treatment for sporadic late‐onset nemaline myopathy with a monoclonal protein
- (2021) Rouslan Kotchetkov et al. INTERNATIONAL JOURNAL OF CANCER
- What is the best treatment approach for sporadic late‐onset nemaline myopathy associated with “monoclonal gammopathy of neurological significance”?
- (2021) Ahmet Emre Eşkazan et al. INTERNATIONAL JOURNAL OF CANCER
- Noteworthy Cardiovascular Involvement with Sporadic Late-onset Nemaline Myopathy
- (2021) Kosuke Matsuzono et al. INTERNAL MEDICINE
- Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
- (2021) Marinos C. Dalakas Neurotherapeutics
- Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: Report of four patients
- (2020) Ali Asghar Okhovat et al. NEUROMUSCULAR DISORDERS
- Nemaline myopathies: a current view
- (2019) Caroline A. Sewry et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Sporadic late-onset nemaline myopathy
- (2019) Elie Naddaf et al. NEUROLOGY
- Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy
- (2018) Rouslan Kotchetkov et al. BONE MARROW TRANSPLANTATION
- Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort
- (2018) Mauro Monforte et al. JOURNAL OF NEUROLOGY
- Update on outcome assessment in myositis
- (2018) Lisa G. Rider et al. Nature Reviews Rheumatology
- Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen
- (2018) Theerawat Kumutpongpanich et al. NEUROMUSCULAR DISORDERS
- Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases
- (2017) Lukas J. Schnitzler et al. Orphanet Journal of Rare Diseases
- Inflammatory Muscle Diseases
- (2015) Marinos C. Dalakas NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy
- (2015) Charles D. Kassardjian et al. JAMA Neurology
- Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy
- (2014) Jessie Aouizerate et al. Acta Neuropathologica Communications
- Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
- (2013) Kathrin Doppler et al. MUSCLE & NERVE
- STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHY
- (2008) O. Benveniste et al. NEUROLOGY
- A "nema" of hope in the treatment of late-onset nemaline myopathy
- (2008) M. C. Dalakas et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started